New Health Sciences (NHS) Manufacturing — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

NHS Manufacturing, founded in 2015, is a U.S.-based contract manufacturer serving the medical device sector, with core competencies in disposables, systems assembly, and distribution. As a subsidiary of New Health Sciences Inc., it leverages a parent company mission focused on innovations in transfusion therapy to offer regulated manufacturing services. The company positions itself as a small, agile partner for device companies needing end-to-end support from design through commercial distribution, particularly targeting smaller clients.

Cell TherapyBiologics

Technology Platform

Contract manufacturing infrastructure for medical devices, with core competencies in disposables setup, systems assembly, and distribution logistics, supported by cGMP processes, design controls, and verification/validation services.

Opportunities

The growing trend of outsourcing in the medical device industry, especially among capital-light startups, presents a significant opportunity.

NHS Manufacturing's niche in providing agile, full-service support from design to distribution positions it well to capture clients underserved by larger CDMOs.

Alignment with the parent company's transfusion medicine focus provides a targeted entry into a specialized and steady market.

Risk Factors

Key risks include dependence on the funding and success of its typically small client base, intense competition in the CDMO space, and the operational and reputational risk associated with potential quality or regulatory compliance failures.

As a subsidiary, its strategic direction and resources are also subject to the priorities of the parent company, New Health Sciences Inc.

Competitive Landscape

NHS Manufacturing competes in the fragmented medical device contract manufacturing market against a range of players from large, global CDMOs to small machine shops. Its primary competitive differentiation is its stated agility, full-service offering for smaller companies, and potential strategic linkages to transfusion medicine. It must compete on technical capability, quality, cost, and customer service.

More companies in United States →